CN1523987A - 治疗牙周疾病的免疫反应调节剂 - Google Patents

治疗牙周疾病的免疫反应调节剂 Download PDF

Info

Publication number
CN1523987A
CN1523987A CNA028118715A CN02811871A CN1523987A CN 1523987 A CN1523987 A CN 1523987A CN A028118715 A CNA028118715 A CN A028118715A CN 02811871 A CN02811871 A CN 02811871A CN 1523987 A CN1523987 A CN 1523987A
Authority
CN
China
Prior art keywords
alkyl
purposes
imidazo
periodontal
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028118715A
Other languages
English (en)
Chinese (zh)
Inventor
苏米塔・B・米特拉
苏米塔·B·米特拉
・E・塞尔伯恩
查尔斯·E·塞尔伯恩
A・托迈
马克·A·托迈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of CN1523987A publication Critical patent/CN1523987A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
CNA028118715A 2001-06-15 2002-06-14 治疗牙周疾病的免疫反应调节剂 Pending CN1523987A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29876801P 2001-06-15 2001-06-15
US60/298,768 2001-06-15

Publications (1)

Publication Number Publication Date
CN1523987A true CN1523987A (zh) 2004-08-25

Family

ID=23151928

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028118715A Pending CN1523987A (zh) 2001-06-15 2002-06-14 治疗牙周疾病的免疫反应调节剂

Country Status (5)

Country Link
EP (1) EP1401437A1 (fr)
JP (1) JP2005519849A (fr)
CN (1) CN1523987A (fr)
CA (1) CA2449754A1 (fr)
WO (1) WO2002102377A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114616234A (zh) * 2019-02-07 2022-06-10 康威(广州)生物科技有限公司 磷咪唑并喹啉胺衍生物、及其药物组合物和应用

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6916925B1 (en) 1999-11-05 2005-07-12 3M Innovative Properties Co. Dye labeled imidazoquinoline compounds
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
UA74852C2 (en) 2000-12-08 2006-02-15 3M Innovative Properties Co Urea-substituted imidazoquinoline ethers
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6660735B2 (en) 2000-12-08 2003-12-09 3M Innovative Properties Company Urea substituted imidazoquinoline ethers
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6525064B1 (en) 2000-12-08 2003-02-25 3M Innovative Properties Company Sulfonamido substituted imidazopyridines
AU2002363954B2 (en) 2001-11-29 2008-04-03 3M Innovative Properties Company Pharmaceutical formulations comprising an immune response modifier
AU2004220469B2 (en) 2001-11-29 2010-07-29 3M Innovative Properties Company Methods of improving skin quality
CA2365732A1 (fr) 2001-12-20 2003-06-20 Ibm Canada Limited-Ibm Canada Limitee Etalonnages
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
CN1674894A (zh) 2002-06-07 2005-09-28 3M创新有限公司 醚取代的咪唑并吡啶
CN1671412B (zh) 2002-08-15 2010-05-26 3M创新有限公司 免疫刺激组合物及刺激免疫反应的方法
WO2004028539A2 (fr) 2002-09-26 2004-04-08 3M Innovative Properties Company Dimeres 1h-imidazo
MXPA05006740A (es) 2002-12-20 2005-10-05 3M Innovative Properties Co Imidazoquinolinas arilo-sustituidas.
EP1578419A4 (fr) 2002-12-30 2008-11-12 3M Innovative Properties Co Complexes immunostimulants
AU2004218349A1 (en) 2003-03-04 2004-09-16 3M Innovative Properties Company Prophylactic treatment of UV-induced epidermal neoplasia
US20040192585A1 (en) 2003-03-25 2004-09-30 3M Innovative Properties Company Treatment for basal cell carcinoma
AU2004229478B2 (en) 2003-04-10 2009-12-24 3M Innovative Properties Company Delivery of immune response modifier compounds
US7176214B2 (en) 2003-05-21 2007-02-13 Bristol-Myers Squibb Company Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
CA2536578A1 (fr) * 2003-09-02 2005-03-10 3M Innovative Properties Company Methodes associees au traitement de pathologies des muqueuses
CA2540541C (fr) 2003-10-03 2012-03-27 3M Innovative Properties Company Imidazoquinolines a substitution alcoxy
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
JP2007513165A (ja) * 2003-12-02 2007-05-24 スリーエム イノベイティブ プロパティズ カンパニー Ｉｒｍ化合物を含む併用薬および治療方法
EP1844201B1 (fr) 2005-02-04 2016-08-24 3M Innovative Properties Company Formulations des gel aqueux contenant des modificateurs de reponse immunitaire
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
MX2011001555A (es) 2008-12-19 2011-04-14 Graceway Pharmaceuticals Llc Formulaciones de imiquimod de baja concentracion de dosis y regimenes de dosis de corta duracion para tratar queratosis actinica.
EP2453747B1 (fr) 2009-07-13 2017-08-30 Medicis Pharmaceutical Corporation Formulations d'imiquimod à intensité de dosage plus faible et régimes posologiques courts pour traiter des verrues génitales et périanales
US20130023736A1 (en) 2011-07-21 2013-01-24 Stanley Dale Harpstead Systems for drug delivery and monitoring
WO2019216438A1 (fr) * 2018-05-11 2019-11-14 株式会社セルテクノロジー Agent thérapeutique pour parodontopathie qui contient un surnageant de culture d'une cellule mésenchymateuse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
US6541485B1 (en) * 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
ATE304849T1 (de) * 2000-07-13 2005-10-15 Alteon Inc Cyanomethyl-substituierte thiazolium- und imidazolium-verbindungen und behandlung von erkrankungen im zusammenhang mit proteinalterung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114616234A (zh) * 2019-02-07 2022-06-10 康威(广州)生物科技有限公司 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
CN114616234B (zh) * 2019-02-07 2024-04-12 康威(广州)生物科技有限公司 磷咪唑并喹啉胺衍生物、及其药物组合物和应用

Also Published As

Publication number Publication date
WO2002102377A1 (fr) 2002-12-27
EP1401437A1 (fr) 2004-03-31
CA2449754A1 (fr) 2002-12-27
JP2005519849A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
CN1523987A (zh) 治疗牙周疾病的免疫反应调节剂
CN1235559C (zh) 皮肤水分保持能力的改善剂
CN1253452C (zh) 硫醚取代的咪唑并喹啉化合物
CN1553951A (zh) 人脐带血衍生的非限制性体干细胞(ussc)
CN1930190A (zh) 透明质酸衍生物及含有其的药剂
CN101060839A (zh) 抑制α－突触核蛋白毒性的化合物、组合物和方法
CN1960758A (zh) 关节炎的治疗剂或预防剂
CN1138773C (zh) 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂
CN1301543A (zh) 皮肤外用剂
CN1939254A (zh) 黄芪甲苷抗皮肤衰老护肤化妆品及其制备方法
CN1896270A (zh) 治疗和预防骨损失的方法
CN1406123A (zh) 皮肤健全化剂
CN1658895A (zh) 护骨素在治疗和／或预防纤维变性疾病中的应用
CN1433469A (zh) 治疗用合成寡核苷酸
CN1031653A (zh) 干蚯蚓粉和含有干蚯蚓粉作为活性成分的抗高脂血，抗糖尿病，抗高血压和抗低血压的制剂的生产方法
CN101080420A (zh) 胸腺特异性蛋白质
CN1826127A (zh) 用于促进热休克蛋白合成的一种含有以富含羽扇醇的提取物为活性成分的化妆品或药学组合物的用途
CN1541278A (zh) 新的神经毒性的分子靶
CN1543347A (zh) Bibn4096与其它抗偏头痛药物组合对治疗偏头痛的用途
CN1816338A (zh) 罗可嘌呤用于治疗淋巴细胞白血病的用途
CN1148175C (zh) L-苏糖酸钙预防、抑制和治疗骨质疏松和佝偻病的用途
CN1543350A (zh) 糖半抗原和聚集的蛋白载体的免疫原性结合物
CN1955175A (zh) 香豆素衍生物及其制法和其药物组合物与用途
CN1220490C (zh) 哌嗪环氧乙烷衍生物在制备用于诱导肿瘤细胞死亡的药物中的应用
CN1307989C (zh) 植烷酸在制备治疗糖尿病的药物中的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication